ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2026
Goldilocks zone: Allergists' perceptions of family anxiety and investment in food allergy oral immunotherapy.
Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundOral immunotherapy (OIT) is an increasingly popular but still contentious treatment option for food allergies. Because most patients receiving OIT are children, families' involvement in treatment is an important part of the discussion of the appropriateness of this treatment option for individual patients.
objectiveTo explore how US-based allergists judge whether OIT is a good fit for specific patients and their families.
methodsProviders were recruited through direct solicitation by email to participate in an in-depth interview about their perceptions of the risks and benefits of current and future food allergy treatment options, including OIT.
resultsA total of 60 interviews were conducted with academic and community providers from 34 states. The primary finding was that as part of the shared decision-making process for OIT, providers actively assessed families' levels of anxiety and investment in this treatment option. They were seeking levels of both that were "just right" and found families with both too low and too high levels of anxiety and investment as a poor fit for OIT.
conclusionProviders used assessments of family anxiety and investment as mechanisms to optimize the benefits and minimize the risk of harm to their patients from OIT and to streamline staffing burdens in their practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.